搜索临床试验以：Lymphoma, Hodgkin's lymphoma , non-Hodgkin's lymphoma
总计10599个结果
-
Novartis Pharmaceuticals撤销
-
University of Sao PauloFundação de Amparo à Pesquisa do Estado de São Paulo未知
-
Novartis Pharmaceuticals终止
-
Baylor College of MedicineThe Methodist Hospital Research Institute招聘中
-
International Extranodal Lymphoma Study Group (IELSG)招聘中
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Alaunos Therapeutics; Intrexon Corporation完全的
-
Molecular Templates, Inc.终止白血病、淋巴细胞性、慢性、B 细胞 | 弥漫性大 B 细胞淋巴瘤 | 血癌 | 血液系统恶性肿瘤 | 小淋巴细胞白血病 | 非霍奇金 B 细胞淋巴瘤美国, 加拿大, 乔治亚州, 白俄罗斯, 西班牙, 以色列, 摩尔多瓦共和国, 波兰, 塞尔维亚, 乌克兰
-
Sheba Medical CenterCity of Hope Medical Center; Amsterdam UMC, location VUmc; University of Göttingen完全的
-
Acrotech Biopharma Inc.完全的
-
AbbVieGenentech, Inc.完全的
-
The First Affiliated Hospital with Nanjing Medical...未知
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Genentech, Inc.终止
-
Ohio State University Comprehensive Cancer Center完全的
-
Massachusetts General HospitalBayer; Dana-Farber Cancer Institute; Beth Israel Deaconess Medical Center; Brigham and Women's Hospital终止
-
Aptevo Therapeutics完全的
-
GlaxoSmithKline完全的
-
University of Kansas Medical CenterMallinckrodt完全的
-
University of Arizona完全的血液肿瘤 | 多发性骨髓瘤 | 贫血，再生障碍性 | 阵发性血红蛋白尿美国
-
GlaxoSmithKline撤销淋巴瘤，滤泡性 | 淋巴瘤，非霍奇金 | 淋巴瘤，小裂细胞，滤泡 | 淋巴瘤，大细胞，滤泡美国
-
Peking UniversityUniversity of Florida未知
-
Stanford University完全的
-
National Cancer Institute (NCI)终止
-
SymBio Pharmaceuticals完全的